Diagnosis, Formulation, and the Risk of Premature Closure
A 29-year-old graduate student is referred after six weeks of poor sleep, racing thoughts, and declining coursework. She reports feeling 'wired but exhausted,' sleeping 3–4 hours, and talking faster than usual. She has no prior psychiatric history and denies substance use, though she drinks three espressos daily and uses a nicotine pouch. Her father has bipolar I disorder. On interview she is articulate, mildly pressured, and scores 18 on a mania symptom scale and 14 on a depression scale. She insists she is 'just stressed' and asks not to be 'labeled.' The trainee's draft note says 'bipolar II disorder, rule out anxiety' and recommends sleep hygiene. A supervisor asks for a revised formulation before the next visit in five days.
1. Identify the main problems with the trainee's draft note and explain what a defensible formulation should include.
Read the worked answer
The draft closes prematurely on bipolar II and buries anxiety as a rule-out, without evidence for hypomanic versus manic duration or for functional change. It also ignores medical and substance contributors - heavy caffeine and nicotine can mimic or worsen activation and insomnia - and gives a low-intensity recommendation (sleep hygiene) mismatched to possible hypomania and family history. A defensible formulation should: (1) describe the current episode's duration, severity, and functional impact; (2) explicitly compare differentials, including bipolar I versus II versus substance/medication-induced or medical causes, major depression, and anxiety; (3) note the family history as a risk factor, not a diagnosis; (4) record the patient's own goals and her objection to labeling; and (5) specify what information is missing and how it will be obtained. Diagnoses should be provisional and tied to criteria, with uncertainty stated.
2. The patient declines medication and asks only for academic accommodations. How should the clinician respond while managing risk over the next five days?
Read the worked answer
Respect autonomy while ensuring safety and continuity. The clinician should acknowledge her concern about labels, explain that a provisional formulation guides care without becoming a permanent identity, and clarify what she wants help with. Collaboratively agree on a short-interval plan: reduce caffeine and nicotine and track sleep and mood daily; schedule a brief check within days; involve a trusted person with consent; and give clear criteria for urgent contact (e.g., no sleep for two nights, escalating goal-directed activity, risky spending, suicidal thoughts). Academic accommodations can be supported with a functional description rather than a diagnostic label where policy allows. Document capacity, the discussion of risks and benefits, and her preferences. If activation worsens or safety concerns emerge, reassess urgency and consider emergency evaluation.
3. Five days later she reports two hours of sleep, has started three business ventures, and says she feels 'invincible.' What changes in the clinical reasoning?
Read the worked answer
The picture now suggests marked functional change and possible mania rather than hypomania, shifting the differential toward bipolar I and raising urgency. The clinician should reassess duration and severity, screen directly for suicidal ideation, risky behavior, psychosis, and substance use, and consider medical causes. Safety planning and close follow-up become central, and urgent psychiatric consultation or emergency evaluation should be considered if impairment or risk is high. The earlier 'stress' framing and sleep-hygiene plan are no longer adequate. This is also a moment to examine the initial reasoning: family history and activation were present early, and the trainee's premature closure on bipolar II plus a low-intensity plan delayed escalation. The revised note should state the working diagnosis, the evidence, the differential, and the contingency plan.